Lv1
98 积分 2024-06-07 加入
Risks Associated with SGLT2 Inhibitors: An Overview
3天前
已完结
The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data
2个月前
已完结
NATURE-PARADOX: Naturally Randomized Trial of Titrating Cumulative Exposure to LDL to Solve the Prevention Paradox
2个月前
已关闭
gout
5个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
5个月前
已完结
皖公网安备34019202002308
